Advertisement

Oral manifestations of anti-neutrophil cytoplasmic antibody-associated vasculitis: an update and narrative review of the literature

Published:December 04, 2022DOI:https://doi.org/10.1016/j.oooo.2022.11.013
      Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a multisystem disorder of small blood vessels subdivided into granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). Oral manifestations (OMs) have been reported to include mucosal ulceration, gingival enlargement, alveolar bone necrosis, tooth loss, oro-antral communication, palatal perforation, parotitis, and candidal infection mainly in GPA. They may appear during the course of the disease, as a disease flare-up, or as the presenting sign. These OMs are often nonspecific and can mimic an array of conditions, therefore formulating a differential diagnosis can be challenging. This review updates the OMs of GPA, and, for the first, time includes OMs of other AAVs. It provides recommendations for the overall assessment and the diagnosis and management of all AAV OMs with considerations for treatment coordination. The role of oral health care providers in multidisciplinary care is highlighted.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      REFERENCES

        • Jennette JC
        • Falk R
        • Bacon P
        • et al.
        2012 revised international Chapel Hill consensus conference nomenclature of vasculitides.
        Arthritis Rheum. 2013; 65: 1-11
        • Okazaki T
        • Shinagawa S
        • Mikage H.
        Vasculitis syndrome-diagnosis and therapy.
        J Gen Fam Med. 2017; 18: 72-78
        • Watts RA
        • Robson J.
        Introduction, epidemiology and classification of vasculitis.
        Best Pract Res Clin Rheumatol. 2018; 32: 3-20
        • McGonagle D
        • Bridgewood C
        • Ramanan AV
        • Meaney JFM
        • Watad A.
        COVID-19 vasculitis and novel vasculitis mimics.
        Lancet Rheumatol. 2021; 3: e224-e233
        • Sinico RA
        • Guillevin L
        Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis.
        Springer, Chaim, Switzerland2020
        • Leacy E
        • Brady G
        • Little MA.
        Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism.
        Rheumatology (Oxford). 2020; 59: iii33-iii41
        • Brogan P
        • Eleftheriou D.
        Vasculitis update: pathogenesis and biomarkers.
        Pediatr Nephrol. 2018; 33: 187-198
        • Wallace ZS
        • Miloslavsky EM.
        Management of ANCA associated vasculitis.
        BMJ. 2020; 368: m421
        • Mohammad AJ.
        An update on the epidemiology of ANCA-associated vasculitis.
        Rheumatology (Oxford). 2020; 59: iii42-iii50
        • Watts RA
        • Mahr A
        • Mohammad AJ
        • Gatenby P
        • Basu N
        • Flores-Suárez LF.
        Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
        Nephrol Dial Transplant. 2015; 30: i14-i22
        • Berti A
        • Cornec D
        • Crowson CS
        • Specks U
        • Matteson EL.
        The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study.
        Arthritis Rheumatol. 2017; 69: 2338-2350
        • Pearce FA
        • Lanyon PC
        • Grainge MJ
        • et al.
        Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population.
        Rheumatology (Oxford). 2016; 55: 1656-1663
        • Weiner M
        • Bjørneklett R
        • Hrušková Z
        • et al.
        Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
        Nephrol Dial Transplant. 2019; 34: 301-308
        • Scott J
        • Hartnett J
        • Mockler D
        • Little MA.
        Environmental risk factors associated with ANCA associated vasculitis: a systematic mapping review.
        Autoimmun Rev. 2020; 19102660
        • Hutton HL
        • Holdsworth SR
        • Kitching AR.
        ANCA-associated vasculitis: pathogenesis, models, and preclinical testing.
        Semin Nephrol. 2017; 37: 418-435
        • Lyons PA
        • Rayner TF
        • Trivedi S
        • et al.
        Genetically distinct subsets within ANCA-associated vasculitis.
        N Engl J Med. 2012; 367: 214-223
        • Kettritz R.
        How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
        Clin Exp Immunol. 2012; 169: 220-228
        • Martin KR
        • Witko-Sarsat V
        Proteinase 3: the odd one out that became an autoantigen.
        J Leukoc Biol. 2017; 102: 689-698
        • Xiao H
        • Hu P
        • Falk RJ
        • Jennette JC.
        Overview of the pathogenesis of ANCA-associated vasculitis.
        Kidney Dis (Basel). 2015; 1: 205-215
        • Jarrot P-A
        • Kaplanski G.
        Pathogenesis of ANCA-associated vasculitis: an update.
        Autoimmun Rev. 2016; 15: 704-713
        • Jennette JC
        • Falk RJ.
        Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.
        Nat Rev Rheumatol. 2014; 10: 463-473
        • Kessenbrock K
        • Krumbholz M
        • Schönermarck U
        • et al.
        Netting neutrophils in autoimmune small-vessel vasculitis.
        Nat Med. 2009; 15: 623-625
        • Xiao H
        • Schreiber A
        • Heeringa P
        • Falk RJ
        • Jennette JC.
        Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
        Am J Pathol. 2007; 170: 52-64
        • Xiao H
        • Heeringa P
        • Hu P
        • et al.
        Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.
        J Clin Invest. 2002; 110: 955-963
        • Müller A
        • Krause B
        • Kerstein-Stähle A
        • et al.
        Granulomatous inflammation in ANCA-associated vasculitis.
        Int J Mol Sci. 2021; 22: 6474
        • Almaani S
        • Fussner LA
        • Brodsky S
        • Meara AS
        • Jayne D
        ANCA-associated vasculitis: an update.
        J Clin Med. 2021; 10: 1446
        • Sacoto G
        • Boukhlal S
        • Specks U
        • Flores-Suárez LF
        • Cornec D.
        Lung involvement in ANCA-associated vasculitis.
        Presse Med. 2020; 49104039
        • Binda V
        • Moroni G
        • Messa P.
        ANCA-associated vasculitis with renal involvement.
        J Nephrol. 2018; 31: 197-208
        • Marzano AV
        • Raimondo MG
        • Berti E
        • Meroni PL
        • Ingegnoli F.
        Cutaneous manifestations of ANCA-associated small vessels vasculitis.
        Clin Rev Allergy Immunol. 2017; 53: 428-438
        • Graf J
        • Imboden J.
        Vasculitis and peripheral neuropathy.
        Curr Opin Rheumatol. 2019; 31: 40-45
        • Pagnoux C.
        Updates in ANCA-associated vasculitis.
        Eur J Rheumatol. 2016; 3: 122-133
        • De Rossi SS
        • Abdelsayed R
        • Ciarrocca KN.
        Gingival lesions in a 21-year-old man.
        J Am Dent Assoc. 2012; 143: 253-258
        • Szczeklik K
        • Włudarczyk A
        • Wawrzycka-Adamczyk K
        • et al.
        Oral manifestations of granulomatosis with polyangiitis—clinical and radiological assessment.
        J Dent Sci. 2019; 14: 54-60
        • Nico MMS
        • Pinto NT
        • Lourenço SV.
        From strawberry gingivitis to palatal perforation: the clinicopathological spectrum of oral mucosal lesions in granulomatosis with polyangiitis.
        J Oral Pathol Med. 2020; 49: 443-449
        • Kertesz T
        • Soowamber M
        • Bubola J
        • Psutka DJ
        • Bradley G.
        Gingival swelling as the initial manifestation of granulomatosis with polyangiitis.
        Head Neck Pathol. 2021; 15: 244-253
        • Porter S
        • Leao J.
        Oral ulcers and its relevance to systemic disorders.
        Aliment Pharmacol Ther. 2005; 21: 295-306
        • Matteo T
        • Andrea G
        • Teggi R.
        ANCA-associated vasculitis—ENT involvement.
        in: Sinico R Guillevin L Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis. Rare Diseases of the Immune System. Springer, Cham2020: 147-161
        • Apoita-Sanz M
        • Blanco-Jauset P
        • Polis-Yanes C
        • et al.
        Granulomatosis with poliangeitis (Wegener's granulomatosis): orofacial manifestations. Systematic review and case report.
        Oral Health Prev Dent. 2020; 18: 929-943
        • Hanisch M
        • Fröhlich LF
        • Kleinheinz J.
        Gingival hyperplasia as first sign of recurrence of granulomatosis with polyangiitis (Wegener's granulomatosis): case report and review of the literature.
        BMC Oral Health. 2016; 17: 33
        • Knight JM
        • Hayduk MJ
        • Summerlin D-J
        • Mirowski GW.
        Strawberry gingival hyperplasia: a pathognomonic mucocutaneous finding in Wegener granulomatosis.
        Arch Dermatol. 2000; 136: 171-173
        • Fonseca F
        • Benites B
        • Ferrari A
        • et al.
        Gingival granulomatosis with polyangiitis (Wegener's granulomatosis) as a primary manifestation of the disease.
        Aust Dent J. 2017; 62: 102-106
        • Msallem B
        • Bassetti S
        • Matter MS
        • Thieringer FM.
        Strawberry gingivitis: challenges in the diagnosis of granulomatosis with polyangiitis on gingival specimens.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 128: e202-e207
        • Alawi F
        • Shields BE
        • Omolehinwa T
        • Rosenbach M.
        Oral granulomatous disease.
        Dermatol Clin. 2020; 38: 429-439
        • Alcântara CEP
        • Noronha MS
        • Cunha JF
        • Flores IL
        • Mesquita RA.
        Granulomatous reaction to hyaluronic acid filler material in oral and perioral region: a case report and review of literature.
        J Cosmet Dermatol. 2018; 17: 578-583
        • Alhassani AA
        • Al-Zahrani MS
        • Zawawi KH.
        Granulomatous diseases: oral manifestations and recommendations.
        Saudi Dent J. 2020; 32: 219-223
        • Al Johani K
        • Moles DR
        • Hodgson T
        • Porter SR
        • Fedele S
        Onset and progression of clinical manifestations of orofacial granulomatosis.
        Oral Dis. 2009; 15: 214-219
        • Woo VL.
        Oral manifestations of Crohn's disease: a case report and review of the literature.
        Case Rep Dent. 2015; 2015830472
        • Piattelli A
        • Favia GF
        • Di Alberti L.
        Oral ulceration as a presenting sign of unknown sarcoidosis mimicking a tumour: report of 2 cases.
        Oral Oncol. 1998; 34: 427-430
        • Bansal R
        • Jain A
        • Mittal S.
        Orofacial tuberculosis: clinical manifestations, diagnosis and management.
        J Family Med Prim Care. 2015; 4: 335-341
        • Folk GA
        • Nelson BL.
        Oral histoplasmosis.
        Head Neck Pathol. 2017; 11: 513-516
        • Kim SY
        • Byun JS
        • Choi JK
        • Jung JK.
        A case report of a tongue ulcer presented as the first sign of occult tuberculosis.
        BMC Oral Health. 2019; 19: 67
        • Du J
        • Zhang Y
        • Liu D
        • Zhu G
        • Zhang Q.
        Hodgkin's lymphoma with marked granulomatous reaction: a diagnostic pitfall.
        Int J Clin Exp Pathol. 2019; 12: 2772-2774
        • Goto H
        • Sugita K
        • Shindo M
        • Yamamoto O.
        Granuloma formation clinically presenting as erythroderma in a patient with peripheral T-cell lymphoma.
        Eur J Dermatol. 2019; 29: 324-326
        • Ortega-Hidalgo B-D
        • Monge K
        • Pérez V
        • del Carmen
        • Villanueva-Vilchis M
        • Gaitán-Cepeda L-A.
        Non-neoplasic and non-syndromic palatal perforations. Presentation of 5 cases and systematic review of the literature.
        J Clin Exp Dent. 2021; 13: e961-e968
        • Bains MK
        • Hosseini-Ardehali M.
        Palatal perforations: past and present. Two case reports and a literature review.
        Br Dent J. 2005; 199: 267-269
      1. Tungare S, Paranjpe AG. Drug induced gingival overgrowth. 2021 Sep 25. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Available at: https://www.ncbi.nlm.nih.gov/books/NBK538518/#_NBK538518_pubdet_.

        • de Sena ACVP
        • de Arruda JAA
        • Costa FPD
        • et al.
        Leukaemic infiltration in the oral and maxillofacial region: an update.
        J Oral Pathol Med. 2021; 50: 558-564
        • Scherrer MAR
        • Rocha VB
        • Garcia LC.
        Behcet's disease: review with emphasis on dermatological aspects.
        An Bras Dermatol. 2017; 92: 452-464
        • Al Azab M
        • Safi M
        • Wang B
        ANCA-associated vasculitis: advancement in pathogenesis, clinical features and management.
        Biomed J Sci & Tech Res. 2019; 21: 15813-15819
        • Li Q
        • Yu L-C
        • Li F-X
        • et al.
        The clinical and pathological features of children with microscopic polyangiitis.
        Front Pediatr. 2021; 9645785
        • Shiboski CH
        • Regezi JA
        • Sanchez HC
        • Silverman Jr, S
        Oral lesions as the first clinical sign of microscopic polyangiitis: a case report.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 94: 707-711
        • Delplace D
        • Da Costa L
        • Goffin L
        • et al.
        Oral ulceration: an unusual manifestation of Churg–Strauss syndrome.
        J Eur Acad Dermatol Venereol. 2007; 21: 969-972
        • Baldini C
        • Ferro F
        • Luciano N
        • et al.
        FRI0453 damage accrual in patients with eosinophilic granulomatosis with polyangiitis (EGPA): analysis of 53 patients.
        Ann Rheum Dis. 2014; 73: 551
        • Ivanoff CS
        • Ivanoff IK
        • Hottel TL.
        Multiple oral ulcerations: a very rare case of Churg-Strauss syndrome with renal disease.
        J Oral Maxillofac Surg Med Pathol. 2018; 30: 175-179
        • Otsuka T
        • Iwata H
        • Kosumi H
        • et al.
        Refractory oral ulcers in eosinophilic granulomatosis with polyangiitis.
        J Dermatol. 2019; 46: e377-e378
        • Irem A
        • Vinciguerra A
        • Lissoni A
        • Danè G
        • Abati S.
        Eosinophilic granulomatosis with polyangiitis and oral lesions: an atypical first sign of the disease. A literature review.
        J Osseointegr. 2021; 13: 43-46
        • Moiseev SV
        • Novikov PI.
        Classification, diagnosis and treatment of ANCA-associated vasculitis.
        World J Rheumatol. 2015; 5: 36-44
        • Kronbichler A
        • Shin JI
        • Lee KH
        • et al.
        Clinical associations of renal involvement in ANCA-associated vasculitis.
        Autoimmun Rev. 2020; 19102495
        • Cornec D
        • Cornec-Le Gall E
        • Fervenza FC
        • Specks U
        ANCA-associated vasculitis—clinical utility of using ANCA specificity to classify patients.
        Nat Rev Rheumatol. 2016; 12: 570-579
        • Argyropoulou OD
        • Goules AV
        • Boutzios G
        • et al.
        Occurrence and antigenic specificity of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in systemic autoimmune diseases.
        Cells. 2021; 10: 2128
        • Folci M
        • Ramponi G
        • Solitano V
        • Brunetta E.
        Serum ANCA as disease biomarkers: clinical implications beyond vasculitis.
        Clin Rev Allergy Immunol. 2022; 63: 107-123
        • Moiseev S
        • Tervaert JWC
        • Arimura Y
        • et al.
        2020 international consensus on ANCA testing beyond systemic vasculitis.
        Autoimmun Rev. 2020; 19102618
        • Draibe J
        • Salama AD.
        Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome.
        Springerplus. 2015; 4: 50
        • Jarrot P-A
        • Chiche L
        • Hervier B
        • et al.
        Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis.
        Medicine (Baltimore). 2016; 95: e3748
        • Derrett-Smith EC
        • Nihtyanova SI
        • Harvey J
        • Salama AD
        • Denton CP.
        Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors.
        Rheumatology (Oxford). 2013; 52: 1824-1831
        • Guellec D
        • Cornec-Le Gall E
        • Groh M
        • et al.
        ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review.
        Autoimmun Rev. 2015; 14: 742-750
        • Sy A
        • Khalidi N
        • Dehghan N
        • et al.
        Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature.
        Semin Arthritis Rheum. 2016; 45: 475-482
        • Arulkumaran N
        • Periselneris N
        • Gaskin G
        • et al.
        Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.
        Rheumatology (Oxford). 2011; 50: 2035-2043
        • Konstantinov KN
        • Ulff-Møller CJ
        • Tzamaloukas AH.
        Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms.
        Autoimmun Rev. 2015; 14: 201-203
        • Langlois V
        • Lesourd A
        • Girszyn N
        • et al.
        Antineutrophil cytoplasmic antibodies associated with infective endocarditis.
        Medicine (Baltimore). 2016; 95: e2564
        • Navarta LM
        • Espul CA
        • Acosta-Rivero N.
        High prevalence of a variety of autoantibodies in a population of hepatitis C virus-infected individuals.
        APMIS. 2018; 126: 515-522
        • Calhan T
        • Sahin A
        • Kahraman R
        • et al.
        Antineutrophil cytoplasmic antibody frequency in chronic hepatitis B patients.
        Dis Markers. 2014; 2014982150
        • Caso F
        • Costa L
        • Ruscitti P
        • et al.
        Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?.
        Autoimmun Rev. 2020; 19102524
        • Izci Duran T
        • Turkmen E
        • Dilek M
        • Sayarlioglu H
        • Arik N.
        ANCA-associated vasculitis after COVID-19.
        Rheumatol Int. 2021; 41: 1523-1529
        • Uppal NN
        • Kello N
        • Shah HH
        • et al.
        De novo ANCA-associated vasculitis with glomerulonephritis in COVID-19.
        Kidney Int Rep. 2020; 5: 2079-2083
        • Moeinzadeh F
        • Dezfouli M
        • Naimi A
        • Shahidi S
        • Moradi H.
        Newly diagnosed glomerulonephritis during COVID-19 infection undergoing immunosuppression therapy, a case report.
        Iran J Kidney Dis. 2020; 14: 239-242
        • Jalalzadeh M
        • Valencia-Manrique JC
        • Boma N
        • Chaudhari A
        • Chaudhari S.
        Antineutrophil cytoplasmic antibody-associated glomerulonephritis in a case of scleroderma after recent diagnosis with COVID-19.
        Cureus. 2021; 13: e12485
        • Csernok E
        • Lamprecht P
        • Gross WL.
        Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
        Curr Opin Rheumatol. 2010; 22: 43-48
        • Pendergraft III, WF
        • Niles JL
        Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.
        Curr Opin Rheumatol. 2014; 26: 42-49
        • Balavoine A-S
        • Glinoer D
        • Dubucquoi S
        • Wémeau J-L.
        Antineutrophil cytoplasmic antibody–positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem?.
        Thyroid. 2015; 25: 1273-1281
        • Kumar B
        • Strouse J
        • Swee M
        • Lenert P
        • Suneja M.
        Hydralazine-associated vasculitis: overlapping features of drug-induced lupus and vasculitis.
        Semin Arthritis Rheum. 2018; 48: 283-287
        • Ji G
        • Zeng X
        • Sandford AJ
        • He J-Q.
        Rifampicin-induced antineutrophil cytoplasmic antibody-positive vasculitis: a case report and review of the literature.
        Int J Clin Pharmacol Ther. 2016; 54: 804-807
        • Gutiérrez-González LA.
        Biological therapy-induced systemic vasculitis.
        Curr Rheumatol Rep. 2016; 18: 39
        • Subesinghe S
        • van Leuven S
        • Yalakki L
        • Sangle S
        • D'Cruz D
        Cocaine and ANCA associated vasculitis-like syndromes—a case series.
        Autoimmun Rev. 2018; 17: 73-77
        • McAdoo SP
        • Hall A
        • Levy J
        • Salama AD
        • Pusey CD.
        Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.
        J Clin Rheumatol. 2012; 18: 336-340
        • Shinkawa Y
        • Hatachi S
        • Yagita M.
        Intravascular large B-cell lymphoma with a high titer of proteinase-3-anti-neutrophil cytoplasmic antibody mimicking granulomatosis with polyangiitis.
        Mod Rheumatol. 2019; 29: 195-197
        • Masiak A
        • Zdrojewski Z
        • Pęksa R
        • et al.
        The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis.
        Reumatologia. 2017; 55: 230-236
        • Schnabel A
        • Holl-Ulrich K
        • Dalhoff K
        • Reuter M
        • Gross W.
        Efficacy of transbronchial biopsy in pulmonary vaculitides.
        Eur Respir J. 1997; 10: 2738-2743
        • Berden AE
        • Ferrario F
        • Hagen EC
        • et al.
        Histopathologic classification of ANCA-associated glomerulonephritis.
        J Am Soc Nephrol. 2010; 21: 1628-1636
        • Berden AE
        • Trejo MAW
        • Bajema IM.
        Investigations in systemic vasculitis—the role of renal pathology.
        Best Pract Res Clin Rheumatol. 2018; 32: 83-93
        • Rowaiye OO
        • Kusztal M
        • Klinger M.
        The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis.
        Clin Kidney J. 2015; 8: 343-350
        • Specks U.
        Polar views in Nephrology Pro: should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?.
        Nephrol Dial Transplant. 2015; 30: 1083-1087
        • Puéchal X
        • Pagnoux C
        • Perrodeau É
        • et al.
        Long-term outcomes among participants in the WEGENT trial of remission-maintenance therapy for granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis.
        Arthritis Rheumatol. 2016; 68: 690-701
        • Specks U
        • Merkel PA
        • Seo P
        • et al.
        Efficacy of remission-induction regimens for ANCA-associated vasculitis.
        N Engl J Med. 2013; 369: 417-427
        • Basu N
        • McClean A
        • Harper L
        • et al.
        The characterisation and determinants of quality of life in ANCA associated vasculitis.
        Ann Rheum Dis. 2014; 73: 207-211
        • Robson J
        • Doll H
        • Suppiah R
        • et al.
        Damage in the ANCA-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.
        Ann Rheum Dis. 2015; 74: 177-184
        • Stein K
        • Farmer J
        • Singhal S
        • et al.
        The use and misuse of antibiotics in dentistry: a scoping review.
        J Am Dent Assoc. 2018; 149 (e5): 869-884